Multicentre dose audit for clinical trials of radiation therapy in Asia

J Radiat Res. 2017 May 1;58(3):372-377. doi: 10.1093/jrr/rrw108.


A dose audit of 16 facilities in 11 countries has been performed within the framework of the Forum for Nuclear Cooperation in Asia (FNCA) quality assurance program. The quality of radiation dosimetry varies because of the large variation in radiation therapy among the participating countries. One of the most important aspects of international multicentre clinical trials is uniformity of absolute dose between centres. The National Institute of Radiological Sciences (NIRS) in Japan has conducted a dose audit of participating countries since 2006 by using radiophotoluminescent glass dosimeters (RGDs). RGDs have been successfully applied to a domestic postal dose audit in Japan. The authors used the same audit system to perform a dose audit of the FNCA countries. The average and standard deviation of the relative deviation between the measured and intended dose among 46 beams was 0.4% and 1.5% (k = 1), respectively. This is an excellent level of uniformity for the multicountry data. However, of the 46 beams measured, a single beam exceeded the permitted tolerance level of ±5%. We investigated the cause for this and solved the problem. This event highlights the importance of external audits in radiation therapy.

Keywords: dose audit; dosimetry; forum for nuclear cooperation in Asia; linac; radiophotoluminescent glass dosimeter.

MeSH terms

  • Asia
  • Clinical Audit*
  • Clinical Trials as Topic*
  • Dose-Response Relationship, Radiation*
  • Humans
  • Multicenter Studies as Topic*
  • Radiometry*
  • Surveys and Questionnaires